NASDAQ Composite opens in less than two hours and Inovio Pharmaceuticals‘s pre-market value is already 17.74% down.
The last session, NASDAQ Composite finished with Inovio Pharmaceuticals sliding 0.33% to $9.13. NASDAQ Composite fell 0.94% to $13,818.41, following last session’s downward trend on what was a somewhat negative trend exchanging session.
Inovio Pharmaceuticals’s last close was $9.16, 270.10% below its 52-week high of $33.79.
Inovio Pharmaceuticals’s Sales
Inovio Pharmaceuticals’s sales growth is a negative 35.9% for the ongoing quarter and 237.1% for the next. The company’s growth estimates for the current quarter and the next is 30.8% and 77.1%, respectively.
Inovio Pharmaceuticals’s last day, last week, and last month’s current volatility was 6.14%, 2.81%, and 2.92%, respectively.
Inovio Pharmaceuticals’s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 7.89% (day), 8.00% (last week), and 6.18% (last month), respectively.
More news about Inovio Pharmaceuticals.